Principales conclusions et analyse des parts de marché des inhibiteurs des récepteurs de l'angiotensine II d'ici 2025-2031
Angiotensin II Receptor Blockers Market Report Analysis
Angiotensin II Receptor Blockers Market
-
CAGR (2023 - 2031)XX% -
Market Size 2023
US$ XX million -
Market Size 2031
US$ XX Million
Report Coverage
- Market size and forecast at global, regional, and country levels for all the key market segments covered under the scope
- Key future trends
- Detailed PEST/Porter’s Five Forces and SWOT analysis
- Industry landscape and competition analysis & recent developments
- Detailed company profiles
- Global and regional market analysis covering key market trends, major players, regulations, and recent market developments
Key Players
- AstraZeneca
- Daichii Sankyo
- Novartis
- Abbvie
- Lupin
- Takeda
- Zydus Cadila
- Sun Pharmaceutical
- Abbott Laboratories
Regional Overview
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et centrale
- Moyen-Orient et Afrique
Market Segmentation
By Type
- Azilsartan
- Candésartan
- Éprosartan
- Irbésartan
- Losartan
- Olmésartan
- Telmisartan
- Valsartan
By Application
- hypertension
- risques cardiovasculaires
- insuffisance rénale dans le diabète
- maladies rénales chroniques
By Géographie
- Amérique du Nord
- Europe
- Asie-Pacifique
- Amérique du Sud et Centrale
Get Free Sample For